0 followers
Vedanta is developing a novel class of therapies that modulate pathways of interaction between the human microbiome and the host immune system.
Bernat Olle
Immunovant
6 followers
Bolt Biotherapeutics
6 followers
C4 Therapeutics
5 followers
Summit Therapeutics
5 followers
Owkin
4 followers
Stemline Therapeutics
3 followers
AnaptysBio
3 followers
Rigel Pharmaceuticals
3 followers
Arcturus Therapeutics
2 followers
Arcutis Biotherapeutics
2 followers
ACROBiosystems
2 followers
Explore companies